1. Home/
  2. Compounds/
  3. tretinoin:navitoclax (4:1 mol/mol)

tretinoin:navitoclax (4:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2tretinoin:navitoclax (4:1 mol/mol)
PharmacoGx tretinoin:navitoclax (4:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to tretinoin:navitoclax (4:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA NEURL1B CTRPv2 pan-cancer AAC 0.18 5e-07
mRNA FAM13C CTRPv2 pan-cancer AAC 0.19 5e-07
mRNA C19orf35 CTRPv2 pan-cancer AAC 0.18 5e-07
mRNA UTP3 CTRPv2 pan-cancer AAC -0.19 5e-07
mRNA RALGAPA2 CTRPv2 pan-cancer AAC 0.18 5e-07
mRNA NCKAP1L CTRPv2 pan-cancer AAC 0.25 5e-07
mRNA NRROS CTRPv2 pan-cancer AAC 0.23 5e-07
mRNA TARBP1 CTRPv2 pan-cancer AAC 0.18 5e-07
mRNA DPYSL5 CTRPv2 pan-cancer AAC 0.2 5e-07
mRNA PODXL2 CTRPv2 pan-cancer AAC 0.19 5e-07
Download CSV